FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904414861> ?p ?o ?g. }

• W2904414861 abstract "The purpose of this study was to assess the prevalence, associated factors, and impact on mortality of primary respiratory disease in a large systemic lupus erythematosus (SLE) retrospective cohort. All adult patients in the RELESSER-TRANS (Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology [SER], cross-sectional phase) registry were retrospectively investigated for the presence of primary pleuropulmonary manifestations. In total 3215 patients were included. At least one pleuropulmonary manifestation was present in 31% of patients. The most common manifestation was pleural disease (21%), followed by lupus pneumonitis (3.6%), pulmonary thromboembolism (2.9%), primary pulmonary hypertension (2.4%), diffuse interstitial lung disease (2%), alveolar hemorrhage (0.8%), and shrinking lung syndrome (0.8%). In the multivariable analysis, the variables associated with the development of pleuropulmonary manifestation were older age at disease onset (odds ratio (OR) 1.03, 95% confidence interval (CI) 1.02–1.04), higher SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) scores (OR 1.03, 95% CI 1.00–1.07), the presence of Raynaud’s phenomenon (OR 1.41, 95% CI 1.09–1.84), secondary antiphospholipid syndrome (OR 2.20, 95% CI 1.63–2.97), and the previous or concomitant occurrence of severe lupus nephritis, (OR 1.48, 95% CI 1.12–1.95) neuropsychiatric manifestations (OR 1.49, 95% CI 1.11–2.02), non-ischemic cardiac disease (OR 2.91, 95% CI 1.90–4.15), vasculitis (OR 1.81, 95% CI 1.25–2.62), hematological manifestations (OR 1.31, 95% CI 1.00–1.71), and gastrointestinal manifestations, excluding hepatitis (OR 2.05, 95% CI 1.14–3.66). Anti-RNP positivity had a clear tendency to significance (OR 1.32, 95% CI 1.00–1.75; P = 0.054). The development of pleuropulmonary manifestations independently contributes to a diminished survival (hazard ratio of 3.13). However, not all complications will influence the prognosis in the same way. Whereas the occurrence of pleural disease or pulmonary thromboembolism has a minimal impact on the survival of these patients, the remaining manifestations have a major impact on mortality. Except for pleural disease, the remaining respiratory manifestations are very uncommon in SLE (<4%). Pleuropulmonary manifestations independently contributed to a decreased survival in these patients." @default.
• W2904414861 created "2018-12-22" @default.
• W2904414861 creator A5008485597 @default.
• W2904414861 creator A5011782353 @default.
• W2904414861 creator A5013324467 @default.
• W2904414861 creator A5022840625 @default.
• W2904414861 creator A5034211653 @default.
• W2904414861 creator A5035309374 @default.
• W2904414861 creator A5036618124 @default.
• W2904414861 creator A5040002919 @default.
• W2904414861 creator A5040669987 @default.
• W2904414861 creator A5048645990 @default.
• W2904414861 creator A5051334937 @default.
• W2904414861 creator A5052029203 @default.
• W2904414861 creator A5057658897 @default.
• W2904414861 date "2018-12-01" @default.
• W2904414861 modified "2023-10-16" @default.
• W2904414861 title "Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort" @default.
• W2904414861 cites W110884291 @default.
• W2904414861 cites W151397696 @default.
• W2904414861 cites W1700856875 @default.
• W2904414861 cites W1779080612 @default.
• W2904414861 cites W1857892850 @default.
• W2904414861 cites W1972252278 @default.
• W2904414861 cites W1978579398 @default.
• W2904414861 cites W1984874770 @default.
• W2904414861 cites W1987783887 @default.
• W2904414861 cites W1994287964 @default.
• W2904414861 cites W1996376376 @default.
• W2904414861 cites W2004006017 @default.
• W2904414861 cites W2025292511 @default.
• W2904414861 cites W2026355082 @default.
• W2904414861 cites W2034396074 @default.
• W2904414861 cites W2044015779 @default.
• W2904414861 cites W2050888852 @default.
• W2904414861 cites W2052162905 @default.
• W2904414861 cites W2053862146 @default.
• W2904414861 cites W2070527591 @default.
• W2904414861 cites W2081172115 @default.
• W2904414861 cites W2083673932 @default.
• W2904414861 cites W2103301773 @default.
• W2904414861 cites W2108905161 @default.
• W2904414861 cites W2141455950 @default.
• W2904414861 cites W2146269734 @default.
• W2904414861 cites W2154808531 @default.
• W2904414861 cites W2155916908 @default.
• W2904414861 cites W2168146874 @default.
• W2904414861 cites W2309455566 @default.
• W2904414861 cites W2333942047 @default.
• W2904414861 cites W2335267188 @default.
• W2904414861 cites W2345001322 @default.
• W2904414861 cites W2396688173 @default.
• W2904414861 cites W2401311701 @default.
• W2904414861 cites W2495491767 @default.
• W2904414861 cites W2507057972 @default.
• W2904414861 cites W2510991651 @default.
• W2904414861 cites W2599712936 @default.
• W2904414861 cites W2606934987 @default.
• W2904414861 cites W2741907939 @default.
• W2904414861 cites W3127828883 @default.
• W2904414861 cites W39002159 @default.
• W2904414861 cites W60402881 @default.
• W2904414861 doi "https://doi.org/10.1186/s13075-018-1776-8" @default.
• W2904414861 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6299951" @default.
• W2904414861 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30567600" @default.
• W2904414861 hasPublicationYear "2018" @default.
• W2904414861 type Work @default.
• W2904414861 sameAs 2904414861 @default.
• W2904414861 citedByCount "37" @default.
• W2904414861 countsByYear W29044148612019 @default.
• W2904414861 countsByYear W29044148612020 @default.
• W2904414861 countsByYear W29044148612021 @default.
• W2904414861 countsByYear W29044148612022 @default.
• W2904414861 countsByYear W29044148612023 @default.
• W2904414861 crossrefType "journal-article" @default.
• W2904414861 hasAuthorship W2904414861A5008485597 @default.
• W2904414861 hasAuthorship W2904414861A5011782353 @default.
• W2904414861 hasAuthorship W2904414861A5013324467 @default.
• W2904414861 hasAuthorship W2904414861A5022840625 @default.
• W2904414861 hasAuthorship W2904414861A5034211653 @default.
• W2904414861 hasAuthorship W2904414861A5035309374 @default.
• W2904414861 hasAuthorship W2904414861A5036618124 @default.
• W2904414861 hasAuthorship W2904414861A5040002919 @default.
• W2904414861 hasAuthorship W2904414861A5040669987 @default.
• W2904414861 hasAuthorship W2904414861A5048645990 @default.
• W2904414861 hasAuthorship W2904414861A5051334937 @default.
• W2904414861 hasAuthorship W2904414861A5052029203 @default.
• W2904414861 hasAuthorship W2904414861A5057658897 @default.
• W2904414861 hasBestOaLocation W29044148611 @default.
• W2904414861 hasConcept C126322002 @default.
• W2904414861 hasConcept C156957248 @default.
• W2904414861 hasConcept C167135981 @default.
• W2904414861 hasConcept C198451711 @default.
• W2904414861 hasConcept C2776912625 @default.
• W2904414861 hasConcept C2777543607 @default.
• W2904414861 hasConcept C2777714996 @default.
• W2904414861 hasConcept C2779134260 @default.
• W2904414861 hasConcept C71924100 @default.
• W2904414861 hasConcept C72563966 @default.
• W2904414861 hasConcept C90924648 @default.

• next